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Abstract An overview of microspheres manufactured for
use in biomedical applications based on recent literature is
presented in this review. Different types of glasses (i.e.
silicate, borate, and phosphates), ceramics and polymer-
based microspheres (both natural and synthetic) in the form
of porous, non-porous and hollow structures that are either
already in use or are currently being investigated within the
biomedical area are discussed. The advantages of using
microspheres in applications such as drug delivery, bone
tissue engineering and regeneration, absorption and
desorption of substances, kinetic release of the loaded drug
components are also presented. This review also reports on
the preparation and characterisation methodologies used
for the manufacture of these microspheres. Finally, a brief
summary of the existing challenges associated with pro-
cessing these microspheres which requires further research
and development are presented.
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Introduction
The development of microspheres fabricated from bio-
polymers (Freiberg and Zhu 2004), bioactive glasses (La-
khkar et al. 2012) and ceramics (Bohner et al. 2013) is an
ongoing challenge for many researchers across the globe.
Microspheres possess several advantages for use in bio-
medical applications over other particle geometries; for
example, they can be manufactured to have a uniform size
and shape which can improve delivery of the spheres to the
specific target site, a larger surface area allowing for suf-
ficient therapeutic coatings and an increase in degradation
rate and ion release and can in some cases be engineered to
be porous or hollow, allowing for encapsulation of other
biomedically relevant components (Cai et al. 2013; Frei-
berg and Zhu 2004; Li et al. 2010). Porous microspheres
can be fabricated with either external or internal porosity,
or even a combination of both, as well as with or without
interconnectivity for cell attachment and spreading over the
available surface area (Chen et al. 2011). Microspheres
containing tailored porosity exhibit greater surface area,
lower mass density, superior cell attachment, cell prolif-
eration, drug absorption and drug release kinetics
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compared to bulk microspheres (Cai et al. 2013). In addi-
tion, these microspheres can be fabricated as stand-alone
products or assembled into three-dimensional (3D) porous
scaffolds (Cai et al. 2013; Li et al. 2010; Perez et al. 2011).
Specific applications have been designated for porous
microspheres based on the composition of these materials
as well as the pore structures (e.g. level of porosity, pore
size, surface area, interconnectivity, etc.). For example,
polymer-based porous microspheres have been extensively
investigated for drug release and as other biological com-
ponent (proteins, cells, growth factors) delivery vehicles
(Cai et al. 2013; Freiberg and Zhu 2004), whereas ceramic
(Komlev et al. 2002; Liu 1996) and glass (Lakhkar et al.
2012) based microspheres have been mainly investigated
for bone tissue regeneration (Choi et al. 2012), radionu-
clide therapy (Sene et al. 2008), dental and orthopaedic
applications (Bohner et al. 2013).
This review aims to provide a general overview of micro-
spheres used in the biomedical sector, focusing on the manu-
facturing methodologies of porous and non-porous microsphere
production, utilising different types of biomaterials.
Manufacture and characterisation of microspheres
Glass microspheres
Glass materials for biomedical applications have long been
investigated for their use in the repair, restoration and
regeneration of tissue within the human body. Larry Hench
revolutionised the use of glassy materials for biomedical
applications since the discovery of Bioglass during the
late 1960s (otherwise known as 45S5). There are now three
major glass types under investigation for biomedical
applications, which include the conventional silicate based
glasses, phosphate-based glasses and borate-based glasses
(Hench 2006; Jones 2013; Rahaman et al. 2011). In terms
of the manufacture of these glasses, many studies have
focused on analysing them in bulk form, rods, discs and
more recently fibres (Abou Neel et al. 2007; Abou Neel
et al. 2009b; Ahmed et al. 2004a, b; Hossain et al. 2014b;
Knowles 2003). However, uses of these materials in
microsphere form are now receiving much attention.
Methods of creating glass spheres have included drop-
ping crushed glass particles down a vertical tube furnace
(Fu et al. 2010), pouring molten glass onto stainless steel
plates to create droplets (Huang et al. 2009), sol–gel
method and spray drying of sols (Todea et al. 2013) and via
the flame spheroidisation process (Lakhkar et al. 2012) (see
Fig. 1). Sols of varying glass compositions (such as alu-
minosilicate) are usually produced by chemical precipita-
tion method and then the microspheres are formed either by
spray drying of the sols or via a solvent evaporation pro-
cess (Todea et al. 2013). On the other hand, vertical tube
furnaces and flame spheroidisation processes involve
grinding the desired composition of the bulk glass into
particles. Usually, if a desired dimension is required the
particles may be separated into varying size ranges via
Fig. 1 Scheme of production of glass microspheres via a Sol–gel, b flame spheroidisation and c tube furnace methods
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sieving. The crushed particles are then transformed into
spherical shapes either by being passed through a vertical
tube furnace (Day et al. 2003; Fu et al. 2010) or being fed
into a hot flame where the high temperatures and surface
tension cause the glass particles to re-melt and form
spheres (Lakhkar et al. 2012).
The flame spheroidisation technique is a relatively fast,
inexpensive process which can easily be scaled-up for
commercialisation purposes. However, for manufacture of
larger microspheres the tube furnace process usually yields
better results. There are several parameters of the flame
spheroidisation technique which can all affect the outcome
of the sphere size and shape; particle separation before
entering the flame is a key criterion to obtain dispersed
uniform spheres; residence time in the flame is also an
important factor as larger particles will require a longer
residence time for the glass to spheroidise. The flame
temperature can also determine the dimensions of the
microspheres and this temperature is generally controlled
by the fuel used. Several studies have utilised varying gases
to create a flame including propane/oxygen, acetylene/
oxygen, petrol/oxygen (Martinelli et al. 2010) and natural
gas/air flames (Conzone et al. 2002; Fu et al. 2010;
Lakhkar et al. 2012; Wang et al. 2006).
Borate-based glass microspheres
Borate-based glass microspheres have been of particular
interest for use as biodegradable radiation delivery vehicles,
in particular Dysprosium lithium-borate microspheres for
the treatment of rheumatoid arthritis (Conzone et al. 2002,
2004). The way in which these spherical vehicles were pre-
viously processed included initial fabrication of glass
microspheres using non-radioactive materials via the flame
spheroidisation technique. These microspheres made for an
ideal candidate for radiation synovectomy due to their uni-
form size and shape, as well as their post processing capa-
bility for generating radioactive microspheres. In order to
yield these microspheres radioactive, the isotopes which
were chemically incorporated into the structure of the glass
were neutron activated, before being injected into the site of
interest. Microsphere size was also an important factor to
consider when fabricating delivery vehicles to accommodate
their constituents, as well as yielding suitable dimensions
which could be delivered and retained at the site of interest.
Conzone et al. (2002, 2004) fabricated microspheres with a
diameter range between 5 and 15 lm to prevent particulate
leakage during radiation synovectomy for the treatment of
rheumatoid arthritis. Although these microspheres exhibited
a uniform shape, their reaction behaviour in simulated
synovial fluid (SSF) was far from uniform. It was seen that
the soluble components of the glass composition (lithium
and Boron) were discharged into the SFF, whereas the
insoluble dysprosium remained chemically intact in the
reacted microspheres resulting in a porous dysprosium
phosphate-rich product. On initial submersion into SSF, the
non-uniform reaction caused the formation of a reaction
layer which later linearly propagated towards the centre of
the microsphere, resulting in *80 % weight loss after
64 days without changing their size and shape. From this it
was found that this non-uniform behaviour was not an out-
come of spheroidisation, but rather due to the soluble and
insoluble constituents of the glass, as identical results were
observed for non-spherodised particles (Conzone et al.
2004). Similar non-uniform reaction of these glass micro-
spheres within PBS solution at 37 C suggested that the
microspheres had completely reacted inside 160 min to form
a dysprosium phosphate-rich reactive product (see Fig. 2)
(Conzone et al. 2004).
Following on from these findings, the resultant amor-
phous, porous reaction products were exploited and a
‘‘novel’’ chemical process was described, yielding porous
microspheres with the same size and shape as the starting
product, however, of a different composition. The non-
uniform reaction process of dysprosium lithium-borate
glass microspheres in phosphate-containing solutions at
37 C presented porous microspheres with a specific sur-
face area of around 200 m2/g, pore volume of 0.2–0.4 cm3/g
and pore diameters of around 30 nm (Conzone and Day
2009).
Alternate two-stage processes involving borate-based
glass microspheres have included the conversion of bulk
Li2O–CaO–B2O3 solid microspheres produced via flame
spheroidisation into hollow hydroxyapatite (HAP) micro-
spheres by reacting the solid microspheres in a buffer
solution (0.25 M K2HPO4) (Huang et al. 2009; Wang et al.
2007, 2006). Briefly, Li2O–CaO–B2O3 glass microspheres
reacted with K2HPO4 solution, resulting initially in heter-
ogeneous precipitation of calcium phosphate after a reac-
tion period of 5 days. Following this, subsequent heat
treatment (at 600 C for 4 h) of these amorphous calcium
phosphate hollow shells resulted in crystallised and porous
HAP microspheres (Huang et al. 2009; Wang et al. 2007,
2006). The mechanism for the production of these hollow
microspheres is illustrated in Fig. 3.
Post heat treatment also resulted in improved strength of
these microspheres; however an increase in brittleness was
also observed. A study conducted by Huang et al. (2009)
measured the strength of these hollow HA microspheres
comparing the as prepared microspheres to the heat-treated
microspheres. It was found that the large surface area of the
as prepared microspheres (135 m2/g) was drastically
reduced after heat treatment for 8 h at 600 C, and on heat
treating at 800 C, the surface area reduced by a factor of
more than 509 to 2.6 m2/g and compressive strength
increased to 35 ± 8 MPa as opposed to 1.6 ± 0.6 MPa for
Prog Biomater (2015) 4:1–19 3
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the as-prepared hollow microspheres. It was suggested that
the geometry of the spheres was more likely to effect the
strength rather than the size, since experiments conducted
on microspheres with diameters of approximately 500 and
800 lm showed no difference in these properties, con-
firming that the compressive strength of structurally and
compositionally homogenous porous spheres are indepen-
dent of their size (Huang et al. 2009). An even greater
specific surface area of 145 ± 5 m2/g was achieved by Fu
et al. (2010) when reacting the glass microspheres with
0.25 M K2HPO4 at a reaction temperature of 60 C, as
these parameters provided a high concentration of phos-
phate ions and a beneficial temperature, causing finer
particle sizes of HA to form, resulting in higher specific
surface area. The same study also found that reducing the
reaction temperature (25 C) and the concentration of
K2HPO4 (0.02 M) resulted in larger ratio between the
hollow core diameter to the external diameter of the
microspheres, thought to be due to a more efficient packing
of the fine HA particles.
Borate glasses are an ideal material to fabricate these
hollow microspheres due to their low network connectivity
and ease of hydrolysis in acidic or basic solutions. Scan-
ning electron microscopy (SEM) images have shown these
microspheres to consist of multiple porous layers which
make up the shell wall of the hollow microspheres. In
general it was found that the outer layers of the shells were
smooth and less porous than the inner layer. The most
effectual variables on pore size have been found to be
K2HPO4 concentration and reaction temperature with low
solution concentrations (0.02 M) and high reaction
Fig. 2 Real-time video
microscopy image showing
non-uniform reaction of
Dysprosium Lithium-Borate
glass microspheres in PBS
solution at 37 C (Conzone
et al. 2004)
Fig. 3 Schematic illustration showing mechanism for production of
hollow, porous HAP microspheres (Wang et al. 2007)
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temperatures (60 C) resulting in the smallest pore sizes
(outer shell wall pore size of *10 nm). This reduction in
pore size and formation of multiple layers are likely to
occur due to densification of the HA shell and separation
during the conversion reaction (Fu et al. 2010; Huang et al.
2009).
Silicate-based glass microspheres
Silicate-based bioglass, glass–ceramics microspheres (Fu
et al. 2012) and silica nanospheres (Sto¨ber et al. 1968) have
been recently investigated for biomedical application. A
glass–ceramic phase can be defined as material where one
or several crystal phases are embedded in a glassy matrix.
The narrow window between the glass thermal transition
temperature (Tg) and its onset of crystallisation can lead to
the conversion of a glass–ceramic material when attempt-
ing thermal processing such as flame spheroidisation. A
study by Fu et al. (2012) evaluated the conversion of sili-
cate-based glass–ceramic microspheres (designated as
45S5c) to a HA-like material. 45S5c glass–ceramic
microspheres with a diameter between 75 and 150 lm
were fabricated using 45S5 glass powder via flame
spheroidisation technique and immersed in 0.01 and 1.0 M
of K2HPO4 solution for a long-term period (10 years) at
room temperature. These results were compared to
microspheres immersed in the same concentration of
K2HPO4 solution for a shorter period of 4 weeks (Fig. 4).
The results showed that even after 10 years, conversion to
a calcium phosphate material was still incomplete. One
possible reason for this was suggested to be due to the
presence of a combeite crystalline phase (Na2O–2CaO–
3SiO2) observed after the spheroidisation process of 45S5
glass. However, using a 3D diffusion model they predicted
a time of approximately 45 years for the full conversion of
45S5 glass–ceramic microspheres in K2HPO4 solution (at
37 C) to HA-like materials, thus suggesting that the
unconverted glass ceramic could remain in the body for
very long periods (Fu et al. 2012).
Other glass–ceramic microspheres fabricated include
aluminium iron silicate glasses, with a main crystalline
phase of magnetite, which were investigated for use in
thermotherapy to treat liver cancers (Martinelli et al. 2010).
Particle sizes of 38–63 lm were spheroidised using flame
to manufacture microspheres; however, the resultant size
distribution of the microspheres produced was greater than
the original particle size, which surpassed 100 lm for some
spheres.
Other methods used to create microspheres have inclu-
ded the sol–gel method via the Sto¨ber process investigated
by Liu et al. (2012). Hydrolysis and polycondensation of
tetraethoxysilane ethanol solution (TEOS) have been
shown to produce monodispersed silica microspheres
(0.3 lm) due to repulsive forces encountered via the neg-
ative charges created under alkaline conditions. On addi-
tion of aluminium nitrate (Al(NO3)3H2O) and silver nitrate
(AgNO3) dissolved in MeOEtOH, amorphous microspheres
(0.4 lm) coated in finer particles resulted, leading to
aggregation of the samples. Although subsequent heat
treatment at 1000 C formed larger microspheres
(8.8–10.1 lm) with smoother surfaces, aggregation of the
particles occurred and it was found that with increasing
Al(NO3)3H2O and AgNO3, aggregation increased linearly.
The antibacterial agent releases, i.e. silver ions, were only
effective during initial submersion of these microspheres in
ultrapure water. This was suggesting that silver nitrate
incorporation occurred only on the surface of the spheres,
creating a sort of short-term antibacterial shell surrounding
a silica core (Kawashita et al. 2003). An alternate method
of adding aluminium tri-isopropoxide (Al(OC3H7)3) pow-
der to a partially hydrolysed TEOS to polycondense the
solution to form Si–O–Al bonds was used. Silver ions were
subsequently added to the ATIP/TEOS mixture in a solu-
tion of ammonia and silver nitrate and a centrifuge was
used to separate solid products isolated from the solution.
The resultant monodispersed microspheres had diameters
ranging from 0.4 to 0.6 lm which did not change following
subsequent heat treatment. Furthermore aggregation of the
microspheres was not observed after application of heat,
and release rates of silver ions in water were a lot more
gradual than before. This more controlled release of silver
ions was due to the fact that during fabrication of the
microspheres, the silver ions enter the SiO4 network
accompanying the aluminium ions in the form of [AlO4]
-
Ag?, and ion exchange with H3O
? in the water slowly
released Ag? ions from the microspheres. These alternate
silver-doped microspheres have vast potential for use as
antibacterial materials.
Fig. 4 Weight loss of 45S5 glass–ceramic microspheres observed
over a period of 4 weeks in 1.0 M K2HPO4 solution (Fu et al. 2012)
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Phosphate-based glass microspheres
The use of phosphate-based glasses (PBGs) for biomedical
applications has seen a huge increase in interest in recent
years which is still growing. This is mainly due to the
desirable properties imparted by these glasses; which
include ease of tailoring degradation profiles by simply
altering their composition, their cytocompability and
varying geometries that have been produced including
fibres (Hossain et al. 2014b; Knowles 2003). Fabricating
PBGs into microspheres has also very recently been
reported (Lakhkar et al. 2012; Sene et al. 2008). Sene et al.
(2008) produced amorphous phosphate glass microspheres
of varying composition of P2O5, Al2O3, SiO2 and MgO
(P2O5 content ranging from 40 to 60 wt % using flame
(oxygen/petrol) spheroidisation process (see Fig. 5a).
They also investigated the degradation of these micro-
spheres in simulated body fluid (SBF) for 21 days at 37 C
and found that the microspheres containing 32.6 at. wt % P
content (MVP9c) was more stable to SBF as less precipi-
tation could be seen on their surface compared to higher P
content microspheres (Please see Fig. 5b, c).
Recently Lakhkar et al. (2012) produced titanium-
doped phosphate glass microspheres also utilising the
flame spheroidisation process. Microspheres were pro-
duced in the range of 63–106 lm and they found that
producing microspheres below 30 lm was difficult as the
particles would agglomerate in both the feed apparatus as
well as in the flame. The larger particle size ranges were
also unsuccessful in creating spheres as a longer residence
time within the flame was required. They also investigated
the structural characterisation and suggested that these
microspheres were comparable to glasses of the same
composition in other forms, such as powders and discs
(Abou Neel et al. 2008, 2007, 2009b). As expected, the
degradation profile of the microspheres behaved in an
exponential manner compared to irregular shaped glasses
of the same composition (Abou Neel et al. 2008, 2009a;
Abou Neel and Knowles 2008), due to the increase in
surface area of the microspheres. Furthermore, it was also
shown that the titanium phosphate glass microspheres
supported favourable MG63 osteoblastic cell attachment
and proliferation on their surface (Lakhkar et al. 2012), as
seen in Fig. 6. Both the SEM and scanning laser confocal
microscopy (SLCM) images showed the microspheres
were covered with a number of cells and some cells
appeared to join neighbouring microspheres by means of
their bioactivity.
Fig. 5 SEM image of a phosphate glass microspheres produced using flame spheroidisation process and b microspheres after 21 days of
immersion in simulated body fluid (SBF) at 37 C a MVP9c and b MVP3 microspheres (Sene et al. 2008)
Fig. 6 a SEM, and b scanning
laser confocal microscopy
(SLCM) images of titanium
phosphate glass microspheres
cultured with MG63 cells on
day 7. Scale bar of SEM image
represents 25 l (Lakhkar et al.
2012)
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Ceramic microspheres
Calcium phosphate (CaP) based ceramic microspheres has
become a common interest to researchers, particularly
hydroxyapatite (HA) (Abou Neel et al. 2008, 2009a; Abou
Neel and Knowles 2008; Abou Neel et al. 2007, 2009b;
Ahmed et al. 2004a, b), and b-tricalcium phosphate (b-
TCP) (Akamatsu et al. 2010; Athanasiou et al. 1998; Auras
et al. 2003; Baldwin et al. 2010; Bergquist et al. 1972;
Berkland 2004) for their use in orthopaedics, dentistry and
the pharmaceutical sectors due to their excellent biocom-
patibility, osteoconductivity and adequate mechanical
properties. These materials tend to be used alone or in
combination with different polymer phases. The advanta-
ges associated with the use of ceramic microspheres
include implantation via a minimally invasive route and
they can provide mechanical support to the target site of
application. Despite these advantages, these ceramic
materials are associated with high brittleness and slow
resorption rates compared to glass microspheres. In addi-
tion, the spherical shape of ceramic particles are considered
to be more suitable for bone defect filling applications due
to their packing and predictable flow characteristics during
injection, compared to irregular shaped micro-particles
(Bohner et al. 2013).
Bohner et al. (2013) highlighted the synthesis and
application of ceramic microspheres in dental and ortho-
paedic applications in a recent review. Various methods
employed for the production of spherical particles with a
broad range of properties according to the starting mate-
rials (such as powders, slurries, pastes and solutions) and
the dispersion phases (gas, solution, and solid). Other
factors include the dispersion apparatus (syringe needles,
spray nozzles, sieves, stirrers, propellers), and consolida-
tion methods such as flame spraying (Cho et al. 2010),
freeze drying (Hong et al. 2011), gelling (Paul and Sharma
1999) and chemical precipitation (Qiu et al. 2008) were
reviewed. Ribeiro et al. (2006) manufactured porous
ceramic microspheres with interconnected porous network
by mixing calcium–titanium–phosphate (CTP) and HA
with alginate solution using a droplet extrusion method
followed by Ca2? induced gelation and subsequent sinter-
ing to burn-off the polymer (see Fig. 7). The ratio of
ceramic phase and polymer solution was a critical param-
eter to alter the size distribution of the microspheres pro-
duced. For example, microspheres with average diameters
of 513 ± 24 and 602 ± 28 lm were reported using a CTP
ceramic-to-polymer ratio of 10/3 and 20/3, respectively,
whereas with HA the average diameters found were
429 ± 46 and 632 ± 40 lm for the same formulation.
Paul and Sharma (1999) developed porous HA micro-
spheres by mixing HA particles with chitosan solution
followed by glutaraldehyde addition. This process induced
hardening leading to the formation of a spherical shape.
The chitosan bonded microspheres produced were then
heated at 500 C for 3 h to burn off the organic matrices
and finally sintered at 1,100 C for 1 h to obtain a porous
structure.
Perez et al. (2011) investigated porous HA and gela-
tin/HA microspheres (pore sizes ranging between 0.5 and
5 l) obtained through a water-in-oil emulsion of calcium
phosphate cement (CPC), where the setting reaction of
the CPC influenced consolidation of the microspheres.
The sphericity and size distribution of the microspheres
were improved via incorporation of gelatin with the
cement as presented in Fig. 8a. They suggested that cell
adhesion (Saos-2 cells) and proliferation (see Fig. 8b, c)
were significantly improved in the hybrid gelatin/HA
microspheres as compared to the control HA
microspheres.
Recently, Sui et al. (2013) developed a simple and
inexpensive chemical transformation process to synthesise
Fig. 7 SEM images of calcium-
titanium-phosphate (CTP)
microspheres a Non-sintered
CTP microspheres and
b sintered CTP microsphere
Ribeiro et al. (2006)
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mesoporous calcium phosphate microspheres (CPMs). At
first they produced calcium carbonate microspheres
(CCMs) by reacting calcium chloride and sodium car-
bonate solutions at room temperatures which was obtained
as a precipitated product. They then converted the CCMs
into mesoporous CPMs by reacting with ammonium
hydrogen phosphate solution. These CPMs were stable in
aqueous media and had higher specific surface area
compared to the CaCO3 microspheres. In addition, CPMs
showed impressive encapsulation efficiency (40 % loading
efficiency) with positively charged biomacromolecules
such as carboxymethyl chitosan and doxorubicin. Calcium
phosphate hollow bioceramic micorspheres with nano-
sized pores were produced by Kawanobe et al. (2010) via
a salt-assisted ultrasonic spray-pyrolysis technique and
investigated vancomycin drug release profiles in physio-
logical saline media at 37 C for osteomyelitis treatment.
They suggested that the microspheres showed two-step
drug release behaviour: from the surface of the micro-
spheres drug release was observed during the first 3 h and
from inside the microspheres due to nano-size pores over
7–9 h.
Though a vast amount of research has been done on
calcium phosphate ceramic microspheres for dental and
orthopaedic applications [highlighted in the recent review
by Bohner et al. (2013)] there still remain some issues
related to these ceramic materials such as high cost, time-
consuming lengthy or complicated manufacturing pro-
cesses, brittleness and slow resorption rates.
Polymer-based microspheres
Polymer-based microspheres have received considerable
attention in recent years due to their potential controlled
drug release characteristics either by leaching the drug
components from the polymer or by degradation of the
polymer matrix (Edlund and Albertsson 2002; Kohane
et al. 2006). As such, selection of biodegradable carrier
matrices (either synthetic or natural) used for microsphere
production is an important factor for delivery of therapeutic
agents (Jung et al. 2000). Most natural polymers such as
proteins (Bergquist et al. 1972; Han et al. 2008), collagen
(Hong et al. 2012; Nagai et al. 2010; Yao et al. 2013),
chitosan (Akamatsu et al. 2010; Maeng et al. 2010; Oli-
veira et al. 2005; Torres et al. 2007) and alginate (Chan
et al. 2002; Eiselt et al. 2000; Lemoine et al. 1998; Mofidi
et al. 2000; Ribeiro et al. 2005) degrade by enzymatic
activity, whereas synthetic polymers such as polylactic acid
(PLA), polycaprolactone (PCL), polyglycolic acid (PGA)
and polylactic-co-glycolic acid (PLGA) undergo hydrolytic
degradation in the body (Jung et al. 2002). Several methods
have also been investigated to produce polymer micro-
spheres for biomedical and pharmaceutical interests (see
Fig. 9), such as emulsion-solvent evaporation (Wang et al.
2002), spray drying (Oliveira et al. 2005; Wang et al.
2004), electro-spinning (Bock et al. 2011; Maeng et al.
2010), gelation followed by emulsification (Chan et al.
2002; Ribeiro et al. 2005), suspension polymerisation
(Bergquist et al. 1972), ultrasonication (Han et al. 2008)
and phase separation (Zhao et al. 2004), which will be
discussed further in the following sections.
PLA microspheres
PLA is one of the most common bioresorbable polymers
used in the biomedical sector due to its degradation rate,
good mechanical properties and availability in different
lactide contents (i.e. L/D ratio) (Athanasiou et al. 1998;
Waris et al. 2004). In addition, thermoplastic PLA can be
formed into various architectural forms including films
(Auras et al. 2003; Hossain et al. 2012), scaffolds (Chung
et al. 2011; Montjovent et al. 2005), fibres (Hossain et al.
2014a, c; Leenslag and Pennings 1987), rods (Felfel et al.
2011) and microspheres (Ehtezazi and Washington 2000;
Izumikawa et al. 1991; Ruan and Feng 2003; Zielhuis et al.
2006). It has also been processed via solvent (Chung et al.
2001) and emulsion-solvent (Hong et al. 2005; Ruan and
Feng 2003) evaporation processes to produce microsphere
Fig. 8 a SEM image of 5 % GEL/OF 900, b Morphology of Saos-2 cells on gelatin/hydroxyapatite microspheres and c after 14 days of culture
Perez et al. (2011)
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structures with varying morphologies. Izumikawa et al.
(1991) investigated progesterone drug-loaded poly (L-lac-
tide) (PLLA) microspheres (diameter 44–88 lm) prepared
via a solvent evaporation method for controlled drug
release applications. They dispersed PLA/methylene chlo-
ride solution into 1 wt % of gelatine/water solution at
constant stirring, followed by removal of the volatile sol-
vent using varying pressures to control the crystallinity of
the polymer microspheres produced. It was reported that
removal of volatile solvent at atmospheric pressure lead to
formation of PLA microspheres with a crystalline structure,
whereas at reduced pressures (i.e. 200 mm Hg), the
escaping solvent produced microspheres with amorphous
polymer matrices. They further suggested that the crystal-
line PLLA microspheres had a rough surface with large
surface areas which revealed rapid drug release profiles
(around 90 % after 145 h) compared to the smooth amor-
phous PLLA microspheres (which revealed drug release
rates of 40 % at 145 h).
Antineoplastic drug paclitaxel-loaded poly(lactic acid)–
poly(ethylene glycol)–poly(lactic acid) (PLA–PEG–PLA)
microspheres of various compositions were produced by
Ruan and Feng (2003) employing the oil-in-water single-
emulsion solvent extraction/evaporation method. They
suggested that incorporation of a water-soluble solvent
(acetone) in the organic solvent (dichloromethane) phase
during microsphere fabrication, along with the presence of
a hydrophilic PEG segment within the hydrophobic PLA
increased porosity of the microspheres and also facilitated
faster paclitaxel release. For example, a (49.6 %) sustained
release of paclitaxel over 1 month was achieved for the
PLA–PEG–PLA microspheres compared to the control
PLGA (L/G ratio = 50/50) microspheres which only
released around 22 % of the drug over the same time
period.
In vitro degradation analysis over a 52-week period of
holmium-loaded PLLA (Ho-PLLA) microspheres (before
and after neutron or gamma irradiation) was investigated
by Zielhuis et al. (2006). PLLA microspheres (diameter
ranging from 20 to 50 l) were produced by dissolving
PLLA in chloroform and then dispersing the solution of
organic solvent into an aqueous solution of PVA (2 wt %)
as presented in Fig. 10a. They reported that incorporation
of Ho within PLLA and neutron irradiation accelerated the
Fig. 9 Typical schemes of production of polymer microspheres employing various methods a emulsion-solvent evaporation, b sol-spray drying
and c electro-spinning processes
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degradation profile of the microspheres, releasing a sig-
nificant portion of disintegrated fragments consisting of
insoluble holmium lactate microcrystals (see Fig. 10c, d)
compared to the other formulations investigated.
PLA microspheres with interconnected porosity (see
Fig. 11) were fabricated by an emulsion-solvent evapora-
tion method based on solution induced phase separation by
Hong et al. (2005). They suggested that the processing
conditions such as organic solvent/aqueous solvent ratio,
PLA concentration, flow, stirring rate and dispersant (such
as, polyvinyl alcohol) concentration all had an important
influence on the size distribution and pattern of pores within
the microspheres produced. For instance, a comparatively
larger pore size had been achieved at a slower stirring rate,
lower organic solvent/aqueous solvent ratio and with a
lower PLA concentration due to longer coalescence time.
Fig. 10 SEM images of a PLLA microspheres, b gamma-irradiated PLLA microspheres, c Ho-PLLA microspheres and d gamma-irradiated Ho-
PLLA microspheres after 52 weeks of incubation in phosphate buffer. Scale bars represent 20 l (Zielhuis et al. 2006)
Fig. 11 SEM images of PLA microspheres produced using emulsion-solvent evaporation process a surface morphology, and b internal cross-
section image (Hong et al. 2005)
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PCL microspheres
A number of synthetic polymers have been investigated for
biomedical and tissue engineering applications; among
these, poly(e-caprolactone) (PCL) is one of the most widely
used bioresorbable polymers. Like PLA, PCL can also be
fabricated into microspheres via several methods, such as
emulsion-solvent evaporation (Luciani et al. 2008), electro-
spinning (Bock et al. 2011) and melt moulding (Lin et al.
1999) processes. For example, (Luciani et al. 2008) pro-
duced protein (Bovine serum albumin)-activated PCL
microspheres by double-emulsion (using dichloromethane
solvent and aqueous PVA solution) and protein-free PCL
microspheres via a single-emulsion technique (Fig. 12a). In
addition, PCL microspheres were sintered at 60 C for 1 h
for the fabrication of bioactive scaffolds as seen in
Fig. 12b. It was also reported that protein-loaded micro-
spheres were successfully included within the scaffold
which provided a sustained release of the protein.
Biodegradable PCL microspheres with diameters rang-
ing from 10 to 20 l with homogeneous embossed textures
were produced (as presented in Fig. 13a) by Bock et al.
(2011) via an electrospraying process. Briefly, PCL solu-
tions (in chloroform and 5–10 wt % concentrations) were
sprayed at 0.2 or 0.5 mL/h using a syringe pump at
10–18 kV and collected on aluminium foil at varying tip-
to-collector distance (15–25 cm). They also investigated
the biological effect of microspheres on the NIH3T3 cells
using DNA quantification assays and direct contact meth-
ods and reported that no toxic residue was detected by this
Fig. 12 SEM micrographs of a PCL microspheres, obtained by single emulsion, b photograph of PCL microspheres sintered scaffold (Luciani
et al. 2008)
Fig. 13 SEM images of a PCL microspheres produced using
electrospraying process (Flow rate 0.2 mL/h, tip-to-collector distance
25 cm and voltage 16 kV). Scale bar represents 100 l (Bock et al.
2011), and b PCL microspheres prepared using polymer blend melt
technique (Lin et al. 1999)
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process, which suggested their suitability for further load-
ing of bioactive components.
Solvent-free PCL microspheres (as presented in
Fig. 13b) from PCL/PEG blends was developed by Lin
et al. (1999); they transformed the molten polymer into
microspheres (with diameters ranging from 1 to 20 l)
using rapid cooling in a freezer (-20 C). As such, the
toxicity associated with the organic solvent residue
resulting from the conventional emulsion/solvent extrac-
tion process could be minimised.
PLGA microspheres
Poly(D,L-lactide-co-glycolic acid) (PLGA), a copolymer of
PLA and polyglycolic acid (PGA) has also been extensively
used in the biomedical field for the synthesis of resorbable
sutures, scaffolds, rods (Khorasani et al. 2008; Kohane et al.
2006; Morrow et al. 1974) and also porous microparticles
(Oh et al. 2011; Ungaro et al. 2009; Wang et al. 2002; Yang
et al. 2009). Porous PLGA microspheres with controllable
pore size have been investigated by Choi et al. (2010). At
first they produced a water-in-oil (W–O) emulsion by ho-
mogenising an aqueous solution of gelatine (7.5 wt %) and
PVA (1 wt %) in a PLGA solution (2 wt % in
dichloromethane). The W–O emulsion was then introduced
into a fluidic device (fabricated using a glass capillary tube,
needle and a poly(vinyl chloride) (PVC) tube), which
transformed the phase into water-in-oil-in-water (W–O–W)
droplets due to continuous flow of the aqueous phase (PVA
solution). The resultant W–O–W droplets were subse-
quently solidified by solvent extraction and evaporation to
generate porous microspheres (Fig. 14a, b). They also
suggested that the pore size could be controlled using a
fluidic device by arranging the syringe tip within the fluidic
device. For example, when the syringe tip was placed at the
bottom position during the phase transformation process,
the W–O–W emulsion rich in small water droplets created
microspheres with small pores due to the small size of the
water droplets. On the other hand, microspheres with larger
pore diameter were produced by placing the syringe tip at
the upper level of the fluidic device.
Natural polymer microspheres
Chitosan (Dhawan and Singla 2003), alginate (Lemoine
et al. 1998), collagen (Hong et al. 2012) and protein (Han
et al. 2008) in the form of microspheres have been the most
widely investigated natural polymers for use in the
Fig. 14 a SEM images of
porous PLGA microspheres
with small and b large pores
(Choi et al. 2010)
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biomedical and tissue engineering fields. These natural
polymers have the advantage that most of them are sus-
ceptible to biodegradation and are generally biocompatible.
Chitosan, a naturally occurring biomacromolecular car-
bohydrate material, is widely employed for use in bio-
medical applications, such as tissue regeneration, bone
void filling materials and as wound treatment due to its gel
forming, self-hardening, bioadhesive, bacteriostatic and
fungistatic properties (d’Ayala et al. 2008). Chitosan
microspheres have been produced via spray drying (Oli-
veira et al. 2005; Torres et al. 2007), emulsification
(Dhawan and Singla 2003), internal gelation (Akamatsu
et al. 2010; Ribeiro et al. 2005), electrospinning and freeze
drying processes. Dhawan and Singla (2003) investigated
nifedipine-chitosan microspheres produced via an emulsi-
fication phase-separation process. They suggested that a
high level of entrapment of nifedipine in the microspheres
was achieved which exhibited excellent swelling proper-
ties. Porous structure within the microspheres could also be
imparted by freezing the chitosan solution (in acetic acid)
as a tiny droplet using liquid nitrogen followed by removal
of solvent utilising freeze drying. Oliveira et al. (2005)
produced chitosan microspheres by spraying chitosan
solution (0.7 % w/v acetic acid solution) using a pressur-
ised atomiser at around 125 C. Water soluble chitosan
microspheres (see Fig. 15a) investigated by Tao et al.
(2013) and they were reported to be more effective in
improving hyperlipidaemia in rats.
Alginates, derived from brown algae or soil bacteria
(Baldwin and Kiick 2010) have also been investigated as
gel-forming biomaterials for the treatment of oesophageal
reflux, dermatology, wound healing and dental impression
materials (Blaine 1947; d’Ayala et al. 2008). Alginate has
also been fabricated into microspheres or microbeads uti-
lising coagulation (Martinsen et al. 1989) and emulsifica-
tion (Lemoine et al. 1998; Mofidi et al. 2000; Wan et al.
1992) processes. Commonly, microspheres have been
formed by coagulating the alginate solution in the form of
fine droplets using calcium chloride solution (Martinsen
et al. 1989). However, a limiting factor highlighted for the
coagulation method was its unsuitability for large-scale
production. Mofidi et al. (2000) investigated the mass
Fig. 15 a SEM image of chitosan microspheres obtained by spray
drying process Tao et al. (2013), b alginate microspheres prepared
using emulsification technique (scale bar 62.5 lm) (Lemoine et al.
1998), c bright-field image of collagen microspheres in mineral oil
produced via emulsification process (scale bar 200 lm) (Hong et al.
2012), and d protein microspheres prepared by ultrasonication (Han
et al. 2008)
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production of alginate microspheres using water-in-oil
emulsion techniques (similar to production of the synthetic
microspheres highlighted above). They stirred the alginate
solution within a non-aqueous (oily phase) media in the
presence of calcium chloride coagulant to form the
microspheres. Non-aggregated alginate microspheres with
an average diameter of 8 lm have been produced via an
emulsification process (see Fig. 15b) by Lemoine et al.
(1998). A high encapsulation efficiency ([90 %) and high
loading (10 % w/w) of bovine serum albumin (BSA)
within the alginate microspheres was achieved. They also
reported the in vitro release profile of BSA which sug-
gested a faster release rate of encapsulated BSA in PBS
media. In addition, they also suggested that decrease of the
release rate could be achieved by coating the alginate
microspheres with poly(L-lysine).
Collagen is the most abundant insoluble fibrous protein
found in extracellular matrix and in connective tissues like
tendons, ligaments and skin. Similar to alginate and the
synthetic polymers, collagen can also be fabricated into
microspheres using the emulsification process (Nagai et al.
2010; Yao et al. 2013). Nagai et al. (2010) produced
injectable collagen microspheres produced via a water-in-
oil emulsion process followed by cross-linking with water-
soluble carbodiimide. They also investigated the sustained
release profile of recombinant human vascular endothelial
growth factor (rhVEGF) from the collagen microspheres
previously loaded with growth factor, which suggested that
the sustained released rhVEGF remained bioactive during
the culture period of 4 weeks. Apart from the conventional
emulsification process for producing collagen microspheres
as presented in Fig. 15c, Hong et al. (2012) developed a
novel methodology for rapid production of collagen
microspheres with encapsulated MDA 231 cells. A single
chip comprising a microfluidic flow system was used to
generate collagen micro-droplets, gelation and extraction
processes of microspheres. At first, collagen micro-droplets
were produced in aqueous and mineral oil phases and
gelled immediately after their generation. The gelled
microspheres were then extracted into a cell culture media
where MDA 231 cells were incorporated within the
microspheres, which suggested higher cell viability as well
as larger number of microspheres recovery compared to the
conventional centrifugation extraction process.
Proteins have been extensively investigated as drug
carriers due their high biological activity, selective uptake
by specific cells, non-antigenicity in denatured form and
ability to provide multiple sites for the attachment of drug
components. Proteins can also be combined with a wide
range of drugs to generate derivatives with tailored phar-
macological properties. Han et al. (2008) have prepared
protein microspheres (see Fig. 15d) with an average
diameter of 1 lm by sonicating silicon oil in an aqueous
solution of protein. They have also investigated the loading
of red dye into the microspheres and suggested that drugs
can be incorporated within the microspheres by simply
dissolving drugs into the oil phase prior to sonication.
Spherical shaped protein molecules have also been pro-
duced by dispersing aqueous proteins into mineral oil and
subsequently polymerised using glutaraldehyde (Bergquist
et al. 1972). However, reproducibility of this protein
microspheres production was suggested to be dependent on
several parameters, which includes the mode of dispersing
proteins into oil, absolute amounts of constituents and pH
of the reaction. They have also investigated the Immuno-
logical activity of the protein microspheres produced and it
was found that they remained practically unaltered after
multiple freezing and thawing and also after several weeks
of storage at -70 C.
Use of microspheres for biomedical applications
One of the most widely prevailing applications for micro-
sphere use is as a drug delivery vehicle. By specifically
selecting biocompatible materials, tailoring the physical
structure (i.e. inclusion of interconnected pores for exam-
ple) and selecting a convenient method of drug incorpo-
ration (e.g. incorporation during or after synthesis/
fabrication), it is possible to control the rate of drug release.
In particular, microspheres are hugely advantageous for
encapsulation of fragile drugs such as nucleic acids and
proteins (Berkland et al. 2004; Kim and Pack 2006; Xia
et al. 2013) by providing protection for biological entities
that would otherwise be rapidly destroyed by the body.
Other applications have included use of microspheres as
controlled release vehicles for vaccines, since their spher-
ical shapes are ideal for take up by antigen-presenting cells.
The vast majority of materials used to fabricate these
spheres for such applications are biopolymers such as PLA,
PLGA and PCL (Freiberg and Zhu 2004; Kim and Pack
2006).
The high sphericity of these particles has also shown
desirable attachment of cells and is thought to improve
delivery to the body via injection, as well as reduce
inflammatory responses associated with foreign body
implantation. Such cells recently investigated include Saos-
2 cells (Perez et al. 2011), OCT-1 osteoblast-like cells (Hu
et al. 2014), neural cells (Lin et al. 2014), chondrocytes
(Chen et al. 2006) and stem cells (Perez et al. 2014), to
mention a few.
Creating porous microspheres has enabled these struc-
tures to be used as tissue regeneration scaffolds, since high
interconnectivity enables the cells to seed more efficiently
throughout the structure, as well as providing a large vol-
ume and surface area for nutrient transport/waste removal,
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and ultimately cell proliferation and differentiation (Cai
et al. 2013).
The large surface area, porosity and volume associated
with microspheres make them an ideal candidate to act as
carriers for biological components such as growth factors,
hormones, therapeutic agents, etc. directly to the target site
(Cai et al. 2013). A number of products based on ceramic
and polymer microspheres (see Table 1) have already
made it to Market with potential use with pharmaceuticals,
biomedical and tissue engineering sectors.
Over recent years much work has been conducted with
the aim to develop and improve the use of microspheres for
biomedical applications. Therefore, due to rapid increase in
scientific research in this field it is expected that new
commercial products with more specific features and
functionality will continue to be developed.
Challenges and future prospects for microspheres
Microsphere production methods developed over the years
have resulted in favourable yields of microspheres in terms
of size and sphericity which also happen to be material
specific. However, it is apparent that some challenges still
remain, the most prominent of which include difficulties
encountered with large-scale production of microspheres.
Many of the manufacturing processes utilised involve
several steps, particularly those fabricated from polymers
and ceramics, making it more difficult to scale up the
process due to cost and time. The numerous steps involved
with fabricating microspheres can also potentially alter the
properties of the material once spheroidised, as is the case
for silicate-based glasses, where thermal processing can
cause crystallisation of the glass. This in turn can affect the
properties of the glass microspheres such as increasing
their brittleness and alter their degradation profiles.
Ceramics can also have brittle characteristics as well as
having high production costs and lengthy and/or compli-
cated manufacturing processes. In addition, achieving
specific control over alternate geometrical features (such as
size, shape, yield and reproducibility) will be the key.
As demand rises for production efficiency, especially for
materials with enhanced properties, microsphere produc-
tion will hopefully rise to the challenge as they hold
superior structural properties related to other irregular
shaped particle morphologies. Microspheres are beginning
to look more promising for use in biomedical applications
with several companies already exploiting these in the
pharmaceutical and health care industry [for example,
MoSci Corporation (USA) and Locate Therapeutics (UK)].
Summary
This article aimed to review the different methods
employed to produce microspheres from various kinds of
materials including glass, ceramics and polymers. Pro-
duction of these microspheres is material dependent;
however, a majority of the fabrication methods used tend to
be quite lengthy and can take several days to prepare, in
most cases requiring several steps for fabrication. For
example, various methods, such as passing ground glass
Table 1 List of commercial products containing ceramic and polymer microspheres currently available
Product name Microsphere Materials/loaded
drugs or biological components
Application Company name
Cerasorb b-TCP Dentistry Curasan
Hydros Brushite calcium phosphate Orthopaedics Biomatlante
Calcibon HA (precipitated) Orthopaedics Biomet
Lupron Depot PLGA loaded with Leuprolide acetate Drug delivery TAP Pharmaceutical Products
Inc.
Nutropin
Depot
PLGA loaded with Recombinant human growth
hormone
Growth hormone regulator Genetech, Inc.
Enantone LP PLGA loaded with Leuprorelin Treatment of prostate cancer Takeda Pharmaceutical
Company Limited
Somatulin LP PLGA loaded with Lanreotide Treatment of acromegaly IPSEN pharma
Sandostatin
LAR
PLGA loaded with Ocreotide Treatment of acromegaly Novartis
Cytodex 3 Collagen (denatured) cross-linked with dextran Microcarriers for various cell lines (tissue
engineering)
GE healthcare
Cultisphere Getalin Microcarriers for various cell lines (tissue
engineering)
Percell Biolytical
Sources: product information has been collected from the respective company’s website
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particles down a vertical tube furnace, sol–gel and spray
drying of sols and flame spheroidisation processes, were
identified to produce glass microspheres. In case of CaP
based ceramic microspheres production precipitation, spray
pyrolysis, electrospraying, emulsification processes were
employed with a broad range of properties. Other methods,
such as emulsion-solvent evaporation, spray drying, elec-
tro-spinning, gelation followed by emulsification, suspen-
sion polymerisation and ultrasonication processes were
discussed to produce polymer microspheres.
As a result of the diversity of microspheres produced
employing various materials, a broad range of properties
can be obtained. For example, materials composition,
particle size distribution, degradation rate, adsorption and
desorption kinetics and porosity will be key for successful
use of the microspheres for biomedical applications. Var-
ious methods have been identified to control the size dis-
tribution in a narrow range, such as initial particle size
monitoring (in case of glass microspheres), precipitation
and/or coagulation reactions as well as stirring time (for
ceramic microspheres), ratio of water and oily phases and
their blending speed (for polymer microspheres). Degra-
dation, release of bioactive components as well as resorb-
ability of the materials used for microsphere production are
also key properties depending on their target medical
applications. Degradation rates can be controlled by alter-
ing the compositions (for glasses) and also blending with
some types of hydrophilic materials. However, ceramic-
based microspheres pose slow resorption rates compared to
the glass and polymer microspheres. Porosity is another
very important property of these microspheres, especially
for drug delivery and tissue engineering applications.
Porous microspheres can provide higher loading efficiency,
adequate transportation of nutrients and further control
over the release behaviour of drugs, growth factors and
other biological components. They are favourable for cell
attachment and proliferation due to their larger surface
area. In addition, porous microspheres can protect cells
encapsulated within the pores from physical damage during
the material handling and delivery processes employed. In
addition, other features such as interconnected and open
porosity, favourable pore size and appropriate mechanical
properties need to be considered during porous micro-
sphere production. Furthermore, despite the superior
properties of porous microspheres, non-porous micro-
spheres can have advantageous features for some specific
applications, such as bone regeneration (in case of load
bearing applications) where higher mechanical properties
are required. In addition to this, precise control over pore
size has been found to be difficult; hence manufacturing
technologies need to be improved to create reproducible
porosity and pore sizes. Furthermore, although consider-
able efforts have been made in limiting the initial
degradation and burst release profiles on implantation
within the body, these areas still warrant further research
and application.
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